Abstract

Primary myocardial involvement is common in systemic sclerosis. There is growing evidence strongly suggesting that this involvement is linked to repeated focal ischemic lesions causing irreversible myocardial fibrosis. It can affect all heart structures. We report the case of a 65 years old male patient, without any personal medical history, admitted for inaugural right heart decompensation. The diagnosis of restrictive cardiomyopathy is based mainly on the following criteria: on echocardiography, hypertrohy of the right ventricle with alteration of the longitudinal systolic function, dilation of the right atrium, with good overall contractility. On right cardiac catheterization: elevation and equalization of the telesystolic pressures of the right atrium, right ventricle, and pulmonary artery with appearance of dip plateau on the right ventricle curve. Scleroderma was evoked considering following statements: the presence of Raynaud's phenomenon, unknown by the patient (presence of dermal sclerosis with pericapillary oedema and capillary dystrophy on capillaroscopy), cutaneous involvement (presence of perivascular and perineural mononuclear infiltrates, with collagen fibers increased in number and thickness), pulmonary involvement (diffuse bilateral interstitial lung disease) and renal involvement (moderately impaired function and positive proteinuria). The concept of cardiac dysfunction in scleroderma and other rheumatologic conditions has received new interest with the advent of newer non-invasive imaging techniques. Therfore, it would be necessary to search the cardiac involvement especially subclinical one in this type of system disease, as well as to confirm the systemic origin in front of certain forms of cardiopathies in particular restrictive cardiomyopathy.

Highlights

  • Primary myocardial involvement is common in systemic sclerosis

  • Increasing evidence strongly suggests that this involvement is related to repeated focal ischemic injury causing irreversible myocardial fibrosis

  • Signs for cardiac involvement have been detected with a prevalence of 15% in a cohort of 953 patients with diffuse cutaneous Systemic Sclerosis (SSc) based on clinical findings, echocardiography, electrocardiography, or Holter monitoring [5]

Read more

Summary

Introduction

Primary myocardial involvement is common in systemic sclerosis. Increasing evidence strongly suggests that this involvement is related to repeated focal ischemic injury causing irreversible myocardial fibrosis. Heart disease in systemic scleroderma is initially often asymptomatic, but it is necessary to screen for it systematically as it has a poor prognosis. Its incidence is estimated between 15% and 35% and can affect all cardiac structures. It can manifest as pericarditis, rhythm or conduction disorder, valve damage, ischemic or hypertrophic myocardial disease and heart failure. High-speed heart failure is not classically described in scleroderma, but rather the prerogative of hyperthyroidism, anemia, Paget's disease, arteriovenous fistulas or vitamin B1 deficiency

Case Report
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call